{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:06:33Z","timestamp":1775891193462,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,10]]},"DOI":"10.7759\/cureus.101210","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:20:27Z","timestamp":1768033227000},"source":"Crossref","is-referenced-by-count":0,"title":["Bone Marrow-Sparing Pelvic Radiotherapy: Clinical Evidence, Dosimetric Constraints, and Clinical Outcomes"],"prefix":"10.7759","author":[{"given":"Reyzane","family":"El Mjabber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Alami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Naim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadila","family":"Kouhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa","family":"El Majjaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Dahbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones R","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017, 28:iv22-40. 10.1093\/annonc\/mdx224","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer-update 2023","volume":"33","author":"Cibula D","year":"2023","unstructured":"Cibula D, Raspollini MR, Planchamp F, et al.. ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer-update 2023. Int J Gynecol Cancer. 2023, 33:649-66. 10.1136\/ijgc-2023-004429","journal-title":"Int J Gynecol Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin N","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, et al.. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021, 31:12-39. 10.1136\/ijgc-2020-002230","journal-title":"Int J Gynecol Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet N","year":"2021","unstructured":"Mottet N, van den Bergh RC, Briers E, et al.. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021, 79:243-62. 10.1016\/j.eururo.2020.09.042","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell LK","year":"2006","unstructured":"Mell LK, Kochanski JD, Roeske JC, et al.. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2006, 66:1356-65. 10.1016\/j.ijrobp.2006.03.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.11.040","article-title":"Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging","volume":"79","author":"Hayman JA","year":"2011","unstructured":"Hayman JA, Callahan JW, Herschtal A, Everitt S, Binns DS, Hicks RJ, Mac Manus M. Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging. Int J Radiat Oncol Biol Phys. 2011, 79:847-52. 10.1016\/j.ijrobp.2009.11.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.95900","article-title":"Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients","volume":"21","author":"Deng B","year":"2024","unstructured":"Deng B, Kong W, Han C, Zhou C, Li J, Song D, Lin Y. Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients. Int J Med Sci. 2024, 21:2000-10. 10.7150\/ijms.95900","journal-title":"Int J Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.07.504","article-title":"Dosimetric predictors of acute hematologic toxicity due to intensity-modulated pelvic radiation therapy with concurrent chemotherapy for Chinese rectal and cervical cancer patients","volume":"102","author":"Yang Y","year":"2018","unstructured":"Yang Y, Li W, Qian J, Zhang J, Shen Y, Tian Y. Dosimetric predictors of acute hematologic toxicity due to intensity-modulated pelvic radiation therapy with concurrent chemotherapy for Chinese rectal and cervical cancer patients. Int J Radiat Oncol Biol Phys. 2018, 102:24. 10.1016\/j.ijrobp.2018.07.504","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu BP","year":"2018","unstructured":"Venkatesulu BP, Mallick S, Lin SH, Krishnan S. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Crit Rev Oncol Hematol. 2018, 123:42-51. 10.1016\/j.critrevonc.2018.01.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101842","article-title":"Hematologic toxicity and bone marrow-sparing strategies in chemoradiation for locally advanced cervical cancer: a systematic review","volume":"16","author":"Konnerth D","year":"2024","unstructured":"Konnerth D, Gaasch A, Zinn A, et al.. Hematologic toxicity and bone marrow-sparing strategies in chemoradiation for locally advanced cervical cancer: a systematic review. Cancers (Basel). 2024, 16:1842. 10.3390\/cancers16101842","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2008.11.006","article-title":"Bone marrow-derived stem cells and radiation response","volume":"19","author":"Greenberger JS","year":"2009","unstructured":"Greenberger JS, Epperly M. Bone marrow-derived stem cells and radiation response. Semin Radiat Oncol. 2009, 19:133-9. 10.1016\/j.semradonc.2008.11.006","journal-title":"Semin Radiat Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03853-7","article-title":"Insights into ionizing radiation-induced bone marrow hematopoietic stem cell injury","volume":"15","author":"Zhang Y","year":"2024","unstructured":"Zhang Y, Chen X, Wang X, Chen J, Du C, Wang J, Liao W. Insights into ionizing radiation-induced bone marrow hematopoietic stem cell injury. Stem Cell Res Ther. 2024, 15:222. 10.1186\/s13287-024-03853-7","journal-title":"Stem Cell Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-025-02652-5","article-title":"Exploring the impact of pelvic radiotherapy dose distribution on lymphocyte counts: a voxel-based analysis","volume":"20","author":"Lee S","year":"2025","unstructured":"Lee S, Kim S, Ha S, Choi KH, Sung W. Exploring the impact of pelvic radiotherapy dose distribution on lymphocyte counts: a voxel-based analysis. Radiat Oncol. 2025, 20:92. 10.1186\/s13014-025-02652-5","journal-title":"Radiat Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch P","year":"1995","unstructured":"Mauch P, Constine L, Greenberger J, et al.. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys. 1995, 31:1319-39. 10.1016\/0360-3016(94)00430-S","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino S","year":"2013","unstructured":"Yovino S, Kleinberg L, Grossman SA, Narayanan M, Ford E. The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest. 2013, 31:140-4. 10.3109\/07357907.2012.762780","journal-title":"Cancer Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2024.100852","article-title":"Understanding the impact of radiation-induced lymphopenia: preclinical and clinical research perspectives","volume":"49","author":"Prades-Sagarra E","year":"2024","unstructured":"Prades-Sagarra E, Yaromina A, Dubois LJ. Understanding the impact of radiation-induced lymphopenia: preclinical and clinical research perspectives. Clin Transl Radiat Oncol. 2024, 49:100852. 10.1016\/j.ctro.2024.100852","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-558825","article-title":"HOXA9 promotes hematopoietic commitment of human embryonic stem cells","volume":"124","author":"Ramos-Mej\u00eda V","year":"2014","unstructured":"Ramos-Mej\u00eda V, Navarro-Montero O, Ayll\u00f3n V, Bueno C, Romero T, Real PJ, Menendez P. HOXA9 promotes hematopoietic commitment of human embryonic stem cells. Blood. 2014, 124:3065-75. 10.1182\/blood-2014-03-558825","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq337","article-title":"HOXA9 regulates miR-155 in hematopoietic cells","volume":"38","author":"Hu YL","year":"2010","unstructured":"Hu YL, Fong S, Largman C, Shen WF. HOXA9 regulates miR-155 in hematopoietic cells. Nucleic Acids Res. 2010, 38:5472-8. 10.1093\/nar\/gkq337","journal-title":"Nucleic Acids Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2024.08.005","article-title":"Epigenetic regulation of hematopoietic stem cell fate","volume":"35","author":"Meng Y","year":"2025","unstructured":"Meng Y, Nerlov C. Epigenetic regulation of hematopoietic stem cell fate. Trends Cell Biol. 2025, 35:217-29. 10.1016\/j.tcb.2024.08.005","journal-title":"Trends Cell Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama T","year":"2006","unstructured":"Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006, 25:977-88. 10.1016\/j.immuni.2006.10.016","journal-title":"Immunity"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-146480","article-title":"TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation","volume":"113","author":"Yamazaki S","year":"2009","unstructured":"Yamazaki S, Iwama A, Takayanagi S, Eto K, Ema H, Nakauchi H. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood. 2009, 113:1250-6. 10.1182\/blood-2008-04-146480","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2022.09.032","article-title":"Comparison of CT and MRI for contouring active bone marrow in bone marrow sparing IMRT of carcinoma cervix and its effects on functional outcomes","volume":"278","author":"Sajeevan S","year":"2022","unstructured":"Sajeevan S, Singh P, Krishnan A, et al.. Comparison of CT and MRI for contouring active bone marrow in bone marrow sparing IMRT of carcinoma cervix and its effects on functional outcomes. Eur J Obstet Gynecol Reprod Biol. 2022, 278:189-94. 10.1016\/j.ejogrb.2022.09.032","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000660","article-title":"Correlations between radiation dose in bone marrow and hematological toxicity in patients with cervical cancer: a comparison of 3DCRT, IMRT, and RapidARC","volume":"26","author":"Chang Y","year":"2016","unstructured":"Chang Y, Yang ZY, Li GL, et al.. Correlations between radiation dose in bone marrow and hematological toxicity in patients with cervical cancer: a comparison of 3DCRT, IMRT, and RapidARC. Int J Gynecol Cancer. 2016, 26:770-6. 10.1097\/IGC.0000000000000660","journal-title":"Int J Gynecol Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)03801-4","article-title":"Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies","volume":"54","author":"Brixey CJ","year":"2002","unstructured":"Brixey CJ, Roeske JC, Lujan AE, et al.. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002, 54:1388-96. 10.1016\/S0360-3016(02)03801-4","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.08.019","article-title":"Positron emission tomography-guided bone marrow-sparing radiation therapy for locoregionally advanced cervix cancer: final results from the INTERTECC phase II\/III trial","volume":"112","author":"Williamson CW","year":"2022","unstructured":"Williamson CW, Sir\u00e1k I, Xu R, et al.. Positron emission tomography-guided bone marrow-sparing radiation therapy for locoregionally advanced cervix cancer: final results from the INTERTECC phase II\/III trial. Int J Radiat Oncol Biol Phys. 2022, 112:169-78. 10.1016\/j.ijrobp.2021.08.019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000292","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy","volume":"24","author":"Hui B","year":"2014","unstructured":"Hui B, Zhang Y, Shi F, et al.. Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy. Int J Gynecol Cancer. 2014, 24:1648-52. 10.1097\/IGC.0000000000000292","journal-title":"Int J Gynecol Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-015-0454-0","article-title":"Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?","volume":"10","author":"Wan J","year":"2015","unstructured":"Wan J, Liu K, Li K, Li G, Zhang Z. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?. Radiat Oncol. 2015, 10:162. 10.1186\/s13014-015-0454-0","journal-title":"Radiat Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110230","article-title":"Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer","volume":"195","author":"Pavarini M","year":"2024","unstructured":"Pavarini M, Alborghetti L, Aimonetto S, et al.. Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer. Radiother Oncol. 2024, 195:110230. 10.1016\/j.radonc.2024.110230","journal-title":"Radiother Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S195989","article-title":"Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation","volume":"11","author":"Kumar T","year":"2019","unstructured":"Kumar T, Schernberg A, Busato F, et al.. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation. Cancer Manag Res. 2019, 11:6285-97. 10.2147\/CMAR.S195989","journal-title":"Cancer Manag Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy T","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, et al.. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021, 22:702-15. 10.1016\/S1470-2045(21)00079-6","journal-title":"Lancet Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer RR","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, et al.. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021, 22:29-42. 10.1016\/S1470-2045(20)30555-6","journal-title":"Lancet Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2024.101662","article-title":"The influence of pelvic bone dose-volume parameters on bone marrow suppression during radiation therapy in patients with stage I to III rectal cancer based on real-world data","volume":"10","author":"Huang B","year":"2025","unstructured":"Huang B, Lv J, Xiong J, et al.. The influence of pelvic bone dose-volume parameters on bone marrow suppression during radiation therapy in patients with stage I to III rectal cancer based on real-world data. Adv Radiat Oncol. 2025, 10:101662. 10.1016\/j.adro.2024.101662","journal-title":"Adv Radiat Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1017\/S1460396923000237","article-title":"Bone marrow sparing RapidArc treatment in locally advanced rectal cancer-can it reduce haematological toxicity?","volume":"22","author":"Joy S","year":"2023","unstructured":"Joy S, Aaron J, Joseph J, et al.. Bone marrow sparing RapidArc treatment in locally advanced rectal cancer-can it reduce haematological toxicity?. J Radiother Pract. 2023, 22:104. 10.1017\/S1460396923000237","journal-title":"J Radiother Pract"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2019.01.005","article-title":"Radiation-related lymphopenia after pelvic nodal irradiation for prostate cancer","volume":"4","author":"Schad MD","year":"2019","unstructured":"Schad MD, Dutta SW, Muller DM, Wijesooriya K, Showalter TN. Radiation-related lymphopenia after pelvic nodal irradiation for prostate cancer. Adv Radiat Oncol. 2019, 4:323-30. 10.1016\/j.adro.2019.01.005","journal-title":"Adv Radiat Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27564","article-title":"Radiation induces iatrogenic immunosuppression by indirectly affecting hematopoiesis in bone marrow","volume":"11","author":"Kapoor V","year":"2020","unstructured":"Kapoor V, Collins A, Griffith K, et al.. Radiation induces iatrogenic immunosuppression by indirectly affecting hematopoiesis in bone marrow. Oncotarget. 2020, 11:1681-90. 10.18632\/oncotarget.27564","journal-title":"Oncotarget"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-5-47","article-title":"Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer","volume":"5","author":"Kitayama J","year":"2010","unstructured":"Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol. 2010, 5:47. 10.1186\/1748-717X-5-47","journal-title":"Radiat Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011435","article-title":"Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer","volume":"97","author":"Wu Z","year":"2018","unstructured":"Wu Z, Zhang J, Cai Y, Deng R, Yang L, Li J, Deng Y. Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer. Medicine (Baltimore). 2018, 97:e11435. 10.1097\/MD.0000000000011435","journal-title":"Medicine (Baltimore)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-020-01623-y","article-title":"Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study","volume":"25","author":"Taguchi A","year":"2020","unstructured":"Taguchi A, Furusawa A, Ito K, et al.. Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study. Int J Clin Oncol. 2020, 25:955-62. 10.1007\/s10147-020-01623-y","journal-title":"Int J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451040-bone-marrow-sparing-pelvic-radiotherapy-clinical-evidence-dosimetric-constraints-and-clinical-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:20:27Z","timestamp":1768033227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451040-bone-marrow-sparing-pelvic-radiotherapy-clinical-evidence-dosimetric-constraints-and-clinical-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.101210","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,10]]}}}